Oruka Therapeutics, Inc. (ORKA)
99.24
-6.11
(-5.80%)
USD |
NASDAQ |
Nov 16, 16:00
98.61
-0.63
(-0.63%)
After-Hours: 05:55
Oruka Therapeutics Price : 99.24 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 104.10 | 107.50 | 98.89 | 99.24 | 989991.0 |
| Nov 13, 2026 | 104.28 | 106.87 | 101.56 | 105.35 | 679679.0 |
| Nov 12, 2026 | 105.10 | 107.01 | 101.50 | 104.99 | 1.142M |
| Nov 11, 2026 | 112.28 | 112.42 | 106.26 | 107.17 | 844084.0 |
| Nov 10, 2026 | 104.02 | 113.24 | 102.78 | 109.50 | 2.612M |
| Nov 09, 2026 | 104.56 | 108.08 | 103.42 | 104.56 | 1.599M |
| Nov 06, 2026 | 97.99 | 103.78 | 96.05 | 102.86 | 1.071M |
| Nov 05, 2026 | 100.02 | 100.73 | 94.05 | 96.02 | 847049.0 |
| Nov 04, 2026 | 102.37 | 102.59 | 96.32 | 101.41 | 790252.0 |
| Nov 03, 2026 | 97.48 | 101.41 | 95.29 | 99.55 | 822164.0 |
| Nov 02, 2026 | 98.85 | 99.83 | 94.28 | 95.43 | 654343.0 |
| Oct 30, 2026 | 94.87 | 97.60 | 94.74 | 96.87 | 634040.0 |
| Oct 29, 2026 | 97.04 | 98.88 | 95.26 | 96.65 | 657291.0 |
| Oct 28, 2026 | 95.26 | 98.45 | 94.17 | 95.97 | 798185.0 |
| Oct 27, 2026 | 89.02 | 96.66 | 89.02 | 95.81 | 1.206M |
| Oct 26, 2026 | 81.98 | 93.42 | 81.98 | 90.33 | 1.943M |
| Oct 23, 2026 | 81.15 | 81.15 | 79.07 | 80.15 | 513996.0 |
| Oct 22, 2026 | 79.06 | 82.14 | 78.36 | 81.15 | 589930.0 |
| Oct 21, 2026 | 79.97 | 81.75 | 79.48 | 79.92 | 953375.0 |
| Oct 20, 2026 | 74.42 | 79.90 | 74.42 | 79.09 | 787723.0 |
| Oct 19, 2026 | 72.40 | 76.35 | 72.30 | 74.48 | 817983.0 |
| Oct 16, 2026 | 73.75 | 74.26 | 70.50 | 71.93 | 1.388M |
| Oct 15, 2026 | 75.53 | 77.89 | 73.15 | 73.87 | 1.222M |
| Oct 14, 2026 | 77.37 | 78.57 | 75.41 | 76.68 | 685301.0 |
| Oct 13, 2026 | 79.47 | 80.19 | 78.18 | 78.19 | 503086.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Tenax Therapeutics, Inc. | 1.48 |
| Exicure, Inc. | 1.07 |
| Century Therapeutics, Inc. | 1.64 |
| Absci Corp. | 7.475 |
| Celularity, Inc. | 0.6191 |
Price Related Metrics
| PEG Ratio | -17.16 |
| Price to Book Value | 5.582 |
| Earnings Yield | -2.49% |
| Market Cap | 6.672B |
| PEGY Ratio | -17.16 |